Showing 2211-2220 of 3980 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/news/21265/A Tale of Two Toxins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-tale-of-two-toxins/22074/From a recent approval to a late-stage candidate, the field is evolving. Experts weigh in on the latest.Making Melanoma Diagnosis and Treatment More Predictable
https://practicaldermatology.com/topics/skin-cancer-photoprotection/making-melanoma-diagnosis-and-treatment-more-predictable/37102/Melanoma can be a very humbling disease. Some of the most talented doctors have been challenged over the years when diagnosing and planning treatment for melanoma because of its variability.COVID-19 Versus Us
https://practicaldermatology.com/topics/practice-management/covid-19-versus-us-1/23253/Our Competition and Our Physical Plant
https://practicaldermatology.com/topics/practice-management/our-competition-and-our-physical-plant/23161/Physician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/21147/6 Tools That Can Benefit Every Dermatology Provider
https://practicaldermatology.com/topics/practice-management/6-tools-that-can-benefit-every-dermatology-provider/23283/Whether you’ve never heard of it or simply forgot about it, each of these tools can improve patient care in the clinic.Patient Outreach: Lost to Follow-up Doesn't Have to Mean Lost
https://practicaldermatology.com/topics/practice-management/patient-outreach-lost-to-follow-up-doesnt-have-to-mean-lost/21531/Effective patient outreach improves outcomes, saves lives, and increases practice revenue.Therapeutic Advances in the Topical Management of Acne
https://practicaldermatology.com/issues/supplements/therapeutic-advances-in-the-topical-management-of-acne/21618/In the Pipeline: New Approaches to Vitiligo, Congenital Ichthyosis, and More
https://practicaldermatology.com/topics/pigmentary-disorders/in-the-pipeline-new-approaches-to-vitiligo-congenital-ichthyosis-and-more/23714/Inflammatory diseases with few or no specific treatments may soon have approved interventions.